Ubiquitin/proteasome pathway impairment in neurodegeneration: Therapeutic implications

Apoptosis

Volumn 15, Issue 11, 2010, Pages 1292-1311

  Huang, Qian ^a   Figueiredo Pereira, Maria E ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Neurodegeneration; Protein aggregation; Therapy; Ubiquitin proteasome pathway

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; ATAXIN 3; BORTEZOMIB; COPPER ZINC SUPEROXIDE DISMUTASE; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN 70; HUNTINGTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; NUCLEAR PROTEIN; OLEUROPEIN; PARKIN; POLYUBIQUITIN; PRESENILIN 1; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C; PROTEIN PA 200; RING FINGER PROTEIN; SUMO PROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VON HIPPEL LINDAU PROTEIN;

ADENOVIRUS; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; CONFORMATIONAL TRANSITION; CONJUGATION; DISEASE COURSE; DOWN SYNDROME; ENDOCYTOSIS; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; HUMAN; HUNTINGTON CHOREA; MICROENVIRONMENT; MISSENSE MUTATION; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NERVE CELL LESION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OLIVE TREE; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PERIPHERAL NEUROPATHY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA INTERFERENCE; SUMOYLATION; UBIQUITINATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 78650034178     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0466-z     Document Type: Article

References (217)

1. A Ciechanover 2005 Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting Cell Death Differ 12 1178 1190 1:CAS:528:DC%2BD2MXnt1Shtro%3D 16094394
2. DH Lee AL Goldberg 1998 Proteasome inhibitors: valuable new tools for cell biologists Trends Cell Biol 8 397 403 1:CAS:528:DyaK1cXmvFWjtbc%3D 9789328
3. JW Yewdell 2001 Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing Trends Cell Biol 11 294 297 1:CAS:528:DC%2BD3MXksVyntb8%3D 11413040
4. AL Haas PM Bright 1985 The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates J Biol Chem 260 12464 12473 1:CAS:528:DyaL2MXlsFKlsL0%3D 2995377
5. RM Gronostajski AB Pardee AL Goldberg 1985 The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts J Biol Chem 260 3344 3349 1:CAS:528:DyaL2MXhsVKltr4%3D 3972829
6. KB Hendil 1988 The 19 S multicatalytic "prosome" proteinase is a constitutive enzyme in HeLa cells Biochem Int 17 471 477 1:CAS:528: DyaL1cXmt1Ohs78%3D 2849441
7. MF Princiotta D Finzi SB Qian J Gibbs S Schuchmann F Buttgereit JR Bennink JW Yewdell 2003 Quantitating protein synthesis, degradation, and endogenous antigen processing Immunity 18 343 354 1:CAS:528:DC%2BD3sXisFKhu7k%3D 12648452
8. A Alves-Rodrigues L Gregori ME Figueiredo-Pereira 1998 Ubiquitin, cellular inclusions and their role in neurodegeneration Trends Neurosci 21 516 520 1:CAS:528:DyaK1cXotVWqurY%3D 9881849
9. T Jung B Catalgol T Grune 2009 The proteasomal system Mol Aspects Med 30 191 296 1:CAS:528:DC%2BD1MXotFOhsrY%3D 19371762
10. A Segref T Hoppe 2009 Think locally: control of ubiquitin-dependent protein degradation in neurons EMBO Rep 10 44 50 1:CAS:528:DC%2BD1MXpt1yq 19079132
11. R Beal Q Deveraux G Xia M Rechsteiner C Pickart 1996 Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting Proc Natl Acad Sci USA 93 861 866 1:CAS:528:DyaK28XnslOqtg%3D%3D 8570649
12. M Hochstrasser 2009 Origin and function of ubiquitin-like proteins Nature 458 422 429 1:CAS:528:DC%2BD1MXjs1Klsbg%3D 19325621
13. RJ Deshaies CA Joazeiro 2009 RING domain E3 ubiquitin ligases Annu Rev Biochem 78 399 434 1:CAS:528:DC%2BD1MXos1Ghur4%3D 19489725
14. M Koegl T Hoppe S Schlenker HD Ulrich TU Mayer S Jentsch 1999 A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly Cell 96 635 644 1:CAS:528:DyaK1MXitVChsrg%3D 10089879
15. FE Reyes-Turcu KH Ventii KD Wilkinson 2009 Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes Annu Rev Biochem 78 363 397 1:CAS:528:DC%2BD1MXos1Ghtbc%3D 19489724
16. K Tanaka 2009 The proteasome: overview of structure and functions Proc Jpn Acad Ser B Phys Biol Sci 85 12 36 1:CAS:528:DC%2BD1MXjtVyhu7o%3D 19145068
17. D Finley 2009 Recognition and processing of ubiquitin-protein conjugates by the proteasome Annu Rev Biochem 78 477 513 1:CAS:528:DC%2BD1MXos1Ghurw%3D 19489727
18. M Rechsteiner C Realini V Ustrell 2000 The proteasome activator 11 S REG (PA28) and class I antigen presentation Biochem J 345 Pt 1 1 15 1:CAS:528:DC%2BD3cXot1KntA%3D%3D 10600633
19. AJ Marques R Palanimurugan AC Matias PC Ramos RJ Dohmen 2009 Catalytic mechanism and assembly of the proteasome Chem Rev 109 1509 1536 1:CAS:528:DC%2BD1MXislKqsLY%3D 19265443
20. M Groll L Ditzel J Lowe D Stock M Bochtler HD Bartunik R Huber 1997 Structure of 20S proteasome from yeast at 2.4 A resolution Nature 386 463 471 1:CAS:528:DyaK2sXisVSqsr0%3D 9087403
21. N Benaroudj P Zwickl E Seemuller W Baumeister AL Goldberg 2003 ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation Mol Cell 11 69 78 1:CAS:528:DC%2BD3sXhtFahu7s%3D 12535522
22. D Bech-Otschir A Helfrich C Enenkel G Consiglieri M Seeger HG Holzhutter B Dahlmann PM Kloetzel 2009 Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome Nat Struct Mol Biol 16 219 225 1:CAS:528:DC%2BD1MXhtVWlsb0%3D 19169257
23. SE Babbitt A Kiss AE Deffenbaugh YH Chang E Bailly H Erdjument-Bromage P Tempst T Buranda LA Sklar J Baumler E Gogol D Skowyra 2005 ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle Cell 121 553 565 1:CAS:528:DC%2BD2MXkslelsL8%3D 15907469
24. M Orlowski S Wilk 2003 Ubiquitin-independent proteolytic functions of the proteasome Arch Biochem Biophys 415 1 5 1:CAS:528:DC%2BD3sXksVaktbo%3D 12801506
25. T Grune KJ Davies 2003 The proteasomal system and HNE-modified proteins Mol Aspects Med 24 195 204 1:CAS:528:DC%2BD3sXlvVClsL0%3D 12892997
26. JS Thrower L Hoffman M Rechsteiner CM Pickart 2000 Recognition of the polyubiquitin proteolytic signal EMBO J 19 94 102 1:CAS:528:DC%2BD3cXht1ylt7w%3D 10619848
27. P Young Q Deveraux RE Beal CM Pickart M Rechsteiner 1998 Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a J Biol Chem 273 5461 5467 1:CAS:528:DyaK1cXhslejtL0%3D 9488668
28. K Husnjak S Elsasser N Zhang X Chen L Randles Y Shi K Hofmann KJ Walters D Finley I Dikic 2008 Proteasome subunit Rpn13 is a novel ubiquitin receptor Nature 453 481 488 1:CAS:528:DC%2BD1cXmt1OrtLc%3D 18497817
29. JA Johnston CL Ward RR Kopito 1998 Aggresomes: a cellular response to misfolded proteins J Cell Biol 143 1883 1898 1:CAS:528:DyaK1MXisFCrtA%3D%3D 9864362
30. C Wojcik GN DeMartino 2003 Intracellular localization of proteasomes Int J Biochem Cell Biol 35 579 589 1:CAS:528:DC%2BD3sXisFShtL8%3D 12672451
31. EAJ Reits AM Benham B Plougastel J Neefjes J Trowsdale 1997 Dynamics of proteasome distribution in living cells EMBO J 16 6087 6094 1:CAS:528: DyaK2sXnt1art7o%3D 9321388
32. RL Welchman C Gordon RJ Mayer 2005 Ubiquitin and ubiquitin-like proteins as multifunctional signals Nat Rev Mol Cell Biol 6 599 609 1:CAS:528: DC%2BD2MXmvVGhtrY%3D 16064136
33. S Elsasser D Finley 2005 Delivery of ubiquitinated substrates to protein-unfolding machines Nat Cell Biol 7 742 749 1:CAS:528: DC%2BD2MXmvVCltLc%3D 16056265
34. RJ Mayer 2003 From neurodegeneration to neurohomeostasis: the role of ubiquitin Drug News Perspect 16 103 108 1:CAS:528:DC%2BD3sXlsFeitr8%3D 12792671
35. B Medicherla AL Goldberg 2008 Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins J Cell Biol 182 663 673 1:CAS:528:DC%2BD1cXhtV2rurzI 18725537
36. J Szeto NA Kaniuk V Canadien R Nisman N Mizushima T Yoshimori DP Bazett-Jones JH Brumell 2006 ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy Autophagy 2 189 199 1:CAS:528:DC%2BD28XnsVWjsbw%3D 16874109
37. H Katayama A Yamamoto N Mizushima T Yoshimori A Miyawaki 2008 GFP-like proteins stably accumulate in lysosomes Cell Struct Funct 33 1 12 1:CAS:528:DC%2BD1MXhsVyhsrfE 18256512
38. NF Bence RM Sampat RR Kopito 2001 Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 1552 1555 1:CAS:528: DC%2BD3MXktVyqs74%3D 11375494
39. Y Wang M Martinez-Vicente U Kruger S Kaushik E Wong EM Mandelkow AM Cuervo E Mandelkow 2009 Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing Hum Mol Genet 18 4153 4170 1:CAS:528: DC%2BD1MXht1CrtrrI 19654187
40. M Tanaka YM Kim G Lee E Junn T Iwatsubo MM Mouradian 2004 Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective J Biol Chem 279 4625 4631 1:CAS:528:DC%2BD2cXps12ksw%3D%3D 14627698
41. MR Cookson PJ Lockhart C McLendon C O'Farrell M Schlossmacher MJ Farrer 2003 RING finger 1 mutations in Parkin produce altered localization of the protein Hum Mol Genet 12 2957 2965 1:CAS:528:DC%2BD3sXovVWqtbY%3D 14519684
42. M Arrasate S Mitra ES Schweitzer MR Segal S Finkbeiner 2004 Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 805 810 1:CAS:528:DC%2BD2cXotl2ktrc%3D 15483602
43. S Mitra AS Tsvetkov S Finkbeiner 2009 Protein turnover and inclusion body formation Autophagy 5 1037 1038 1:CAS:528:DC%2BC3cXmt1Cgtg%3D%3D 19838079
44. HT Orr 2004 Neurodegenerative disease: neuron protection agency Nature 431 747 748 1:CAS:528:DC%2BD2cXotl2ksLo%3D 15483586
45. F Saudou S Finkbeiner D Devys ME Greenberg 1998 Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions Cell 95 55 66 1:CAS:528:DyaK1cXmslWlsrs%3D 9778247
46. Z Wang ME Figueiredo-Pereira 2005 Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity Mol Cell Neurosci 29 222 231 1:CAS:528:DC%2BD2MXks1Wltb8%3D 15911346
47. LT Arnaud N Myeku ME Figueiredo-Pereira 2009 Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells J Neurochem 110 328 342 1:CAS:528:DC%2BD1MXosVCmtbk%3D 19457109
48. WC Wigley RP Fabunmi MG Lee CR Marino S Muallem GN DeMartino PJ Thomas 1999 Dynamic association of proteasomal machinery with the centrosome J Cell Biol 145 481 490 1:CAS:528:DyaK1MXivFKnsbk%3D 10225950
49. R Garcia-Mata Z Bebok EJ Sorscher ES Sztul 1999 Characterization and dynamics of aggresome formation by a cytosolic GFP- chimera J Cell Biol 146 1239 1254 1:CAS:528:DyaK1MXmt1Gnsrg%3D 10491388
50. RP Fabunmi WC Wigley PJ Thomas GN DeMartino 2000 Activity and regulation of the centrosome-associated proteasome J Biol Chem 275 409 413 1:CAS:528:DC%2BD3cXjvVKisg%3D%3D 10617632
51. KD Ogburn ME Figueiredo-Pereira 2006 Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates J Biol Chem 281 23274 23284 1:CAS:528:DC%2BD28XnvVWjur0%3D 16774923
52. G Cappelletti B Pedrotti MG Maggioni R Maci 2001 Microtubule assembly is directly affected by MPP(+)in vitro Cell Biol Int 25 981 984 1:CAS:528:DC%2BD3MXntlWqsrc%3D 11589612
53. FJ Diaz-Corrales M Asanuma I Miyazaki K Miyoshi N Ogawa 2005 Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration Neuroscience 133 117 135 1:CAS:528:DC%2BD2MXktVOltLo%3D 15893636
54. LE Marshall RH Himes 1978 Rotenone inhibition of tubulin self-assembly Biochim Biophys Acta 543 590 594 1:CAS:528:DyaE1MXmslWitA%3D%3D 568944
55. S Roy B Zhang VM Lee JQ Trojanowski 2005 Axonal transport defects: a common theme in neurodegenerative diseases Acta Neuropathol 109 5 13 15645263
56. H Lelouard V Ferrand D Marguet J Bania V Camosseto A David E Gatti P Pierre 2004 Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins J Cell Biol 164 667 675 1:CAS:528:DC%2BD2cXhvVOnu70%3D 14981091
57. F Ebstein N Lange S Urban U Seifert E Kruger PM Kloetzel 2009 Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system Int J Biochem Cell Biol 41 1205 1215 1:CAS:528:DC%2BD1MXitVGjtrY%3D 19028597
58. R Hartmann-Petersen CA Semple CP Ponting KB Hendil C Gordon 2003 UBA domain containing proteins in fission yeast Int J Biochem Cell Biol 35 629 636 1:CAS:528:DC%2BD3sXisFShtLs%3D 12672455
59. V Su AF Lau 2009 Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation Cell Mol Life Sci 66 2819 2833 1:CAS:528:DC%2BD1MXps1Cqtrk%3D 19468686
60. CR Wilkinson M Seeger R Hartmann-Petersen M Stone M Wallace C Semple C Gordon 2001 Proteins containing the UBA domain are able to bind to multi-ubiquitin chains Nat Cell Biol 3 939 943 1:CAS:528:DC%2BD3MXnslegsLw%3D 11584278
61. K Madura 2002 The ubiquitin-associated (UBA) domain: on the path from prudence to prurience Cell Cycle 1 235 244 1:CAS:528:DC%2BD38Xnt1yitbc%3D 12429939
62. J Shin 1998 P62 and the sequestosome, a novel mechanism for protein metabolism Arch Pharm Res 21 629 633 1:CAS:528:DyaK1MXjtFeg 9868528
63. S Kim EA Nollen K Kitagawa VP Bindokas RI Morimoto 2002 Polyglutamine protein aggregates are dynamic Nat Cell Biol 4 826 831 1:CAS:528: DC%2BD38XnsVGktbk%3D 12360295
64. PB Tran RJ Miller 1999 Aggregates in neurodegenerative disease: crowds and power? Trends Neurosci 22 194 197 1:CAS:528:DyaK1MXivVOktbw%3D 10322490
65. D Sharma S Sharma S Pasha SK Brahmachari 1999 Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions FEBS Lett 456 181 185 1:CAS:528:DyaK1MXlsFWgsb0%3D 10452554
66. E Trushina MP Heldebrant CM Perez-Terzic R Bortolon IV Kovtun JD Badger A Terzic A Estevez AJ Windebank RB Dyer J Yao CT McMurray 2003 Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease Proc Natl Acad Sci USA 100 12171 12176 1:CAS:528: DC%2BD3sXotlGlu7g%3D 14527999
67. JH Kordower Y Chu RA Hauser TB Freeman CW Olanow 2008 Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease Nat Med 14 504 506 1:CAS:528:DC%2BD1cXlsFCmsrg%3D 18391962
68. JH Kordower Y Chu RA Hauser CW Olanow TB Freeman 2008 Transplanted dopaminergic neurons develop PD pathologic changes: a second case report Mov Disord 23 2303 2306 19006193
69. JY Li E Englund JL Holton D Soulet P Hagell AJ Lees T Lashley NP Quinn S Rehncrona A Bjorklund H Widner T Revesz O Lindvall P Brundin 2008 Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation Nat Med 14 501 503 1:CAS:528:DC%2BD1cXlsFCmsrs%3D 18391963
70. F Cicchetti S Saporta RA Hauser M Parent M Saint-Pierre PR Sanberg XJ Li JR Parker Y Chu EJ Mufson JH Kordower TB Freeman 2009 Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration Proc Natl Acad Sci USA 106 12483 12488 1:CAS:528:DC%2BD1MXpslCisrs%3D 19620721
71. PH Ren JE Lauckner I Kachirskaia JE Heuser R Melki RR Kopito 2009 Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates Nat Cell Biol 11 219 225 1:CAS:528:DC%2BD1MXht1Oqtrg%3D 19151706
72. B Frost RL Jacks MI Diamond 2009 Propagation of tau misfolding from the outside to the inside of a cell J Biol Chem 284 12845 12852 1:CAS:528: DC%2BD1MXltlemsro%3D 19282288
73. P Desplats HJ Lee EJ Bae C Patrick E Rockenstein L Crews B Spencer E Masliah SJ Lee 2009 Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein Proc Natl Acad Sci USA 106 13010 13015 1:CAS:528:DC%2BD1MXhtVKru7%2FM 19651612
74. EG McGeer A Klegeris PL McGeer 2005 Inflammation, the complement system and the diseases of aging Neurobiol Aging 26 Suppl 1 94 97 16198446
75. M Bjorkqvist EJ Wild J Thiele A Silvestroni R Andre N Lahiri E Raibon RV Lee CL Benn D Soulet A Magnusson B Woodman C Landles MA Pouladi MR Hayden A Khalili-Shirazi MW Lowdell P Brundin GP Bates BR Leavitt T Moller SJ Tabrizi 2008 A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease J Exp Med 205 1869 1877 18625748
76. S Boillee VC Vande DW Cleveland 2006 ALS: a disease of motor neurons and their nonneuronal neighbors Neuron 52 39 59 1:CAS:528:DC%2BD28XhtFensbfP 17015226
77. J Lowe A Blanchard K Morrell G Lennox L Reynolds M Billett M Landon RJ Mayer 1988 Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease J Pathol 155 9 15 1:STN:280:DyaL1c3ksV2gsA%3D%3D 2837558
78. J Lowe G Lennox D Jefferson K Morrell D McQuire T Gray M Landon FJ Doherty RJ Mayer 1988 A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin Neurosci Lett 94 203 210 1:STN:280:DyaL1M3gtFGhtw%3D%3D 2853853
79. JN Keller KB Hanni WR Markesbery 2000 Impaired proteasome function in Alzheimer's disease J Neurochem 75 436 439 1:CAS:528:DC%2BD3cXkt12qur8%3D 10854289
80. KS McNaught P Jenner 2001 Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci Lett 297 191 194 1:CAS:528: DC%2BD3MXhsFejsb0%3D 11137760
81. JN Keller J Gee Q Ding 2002 The proteasome in brain aging Ageing Res Rev 1 279 293 1:CAS:528:DC%2BD38XosFSmtbo%3D 12039443
82. P Jenner 2003 Oxidative stress in Parkinson's disease Ann Neurol 53 Suppl 3 S26 S36 1:CAS:528:DC%2BD3sXjtFGitLs%3D 12666096
83. FW van Leeuwen DP de Kleijn HH van den Hurk A Neubauer MA Sonnemans JA Sluijs S Koycu RDJ Ramdjielal A Salehi GJM Martens FG Grosveld J Peter H Burbach EM Hol 1998 Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients Science 279 242 247 9422699
84. T Kitada S Asakawa S Minoshima Y Mizuno N Shimizu 2000 Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene Mamm Genome 11 417 421 1:CAS:528:DC%2BD3cXks1OksLo%3D 10818204
85. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 605 608 1:CAS:528:DyaK1cXis1Sqsrc%3D 9560156 (Pubitemid 28207717)
86. E Leroy R Boyer G Auburger B Leube G Ulm E Mezey G Harta MJ Brownstein S Jonnalagada T Chernova A Dehejia C Lavedan T Gasser PJ Steinbach KD Wilkinson MH Polymeropoulos 1998 The ubiquitin pathway in Parkinson's disease Nature 395 451 452 1:CAS:528:DyaK1cXms1antLo%3D 9774100
87. DJ Moore VL Dawson TM Dawson 2003 Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses Neuromolecular Med 4 95 108 14528055
88. S Przedborski M Vila V Jackson-Lewis 2003 Neurodegeneration: what is it and where are we? J Clin Invest 111 3 10 1:CAS:528:DC%2BD3sXhvVagug%3D%3D 12511579
89. Gray DA, Tsirigotis M and Woulfe J (2003) Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowl Environ 2003:RE6
90. G Carrard A Bulteau I Petropoulos B Friguet 2002 Impairment of proteasome structure and function in aging Int J Biochem Cell Biol 34 1461 1:CAS:528:DC%2BD38XmsVertrw%3D 12200039
91. M Gaczynska PA Osmulski WF Ward 2001 Caretaker or undertaker? The role of the proteasome in aging Mech Ageing Dev 122 235 254 1:CAS:528: DC%2BD3MXisVGrtrc%3D 11311314
92. VA Vernace T Schmidt-Glenewinkel ME Figueiredo-Pereira 2007 Aging and regulated protein degradation: who has the UPPer hand? Aging Cell 6 599 606 1:CAS:528:DC%2BD2sXhtFeksLnE 17681036
93. VA Vernace L Arnaud T Schmidt-Glenewinkel ME Figueiredo-Pereira 2007 Aging perturbs 26S proteasome assembly in Drosophila melanogaster FASEB J 21 2672 2682 1:CAS:528:DC%2BD2sXhtVehurfK 17413001
94. RJ Mayer J Arnold L Laszlo M Landon J Lowe 1991 Ubiquitin in health and disease Biochim Biophys Acta 1089 141 157 1:CAS:528:DyaK3MXks12gurg%3D 1647208
95. FW van Leeuwen EM Hol DF Fischer 2006 Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system J Alzheimers Dis 9 319 325 16914870
96. YA Lam CM Pickart A Alban M Landon C Jamieson R Ramage RJ Mayer R Layfield 2000 Inhibition of the ubiquitin-proteasome system in Alzheimer's disease Proc Natl Acad Sci USA 97 9902 9906 1:CAS:528:DC%2BD3cXmtlehsr8%3D 10944193
97. K Lindsten FM de Vrij LG Verhoef DF Fischer FW van Leeuwen EM Hol MG Masucci NP Dantuma 2002 Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J Cell Biol 157 417 427 1:CAS:528:DC%2BD38XjtleltL8%3D 11980917
98. EM Tank HL True 2009 Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates PLoS Genet 5 e1000382 19214209
99. Z Tan X Sun FS Hou HW Oh LG Hilgenberg EM Hol FW van Leeuwen MA Smith DK O'Dowd SS Schreiber 2007 Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration Cell Death Differ 14 1721 1732 1:CAS:528:DC%2BD2sXhtVCisbvJ 17571083
100. Fischer DF, van DR, van TP, Hobo B, Verhage MC, van der Schors RC, Li KW, van MJ, Hol EM and van Leeuwen FW (2009) Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin. Neurobiol Aging 30:847-863
101. CB Lucking A Durr V Bonifati J Vaughan G De Michele T Gasser BS Harhangi G Meco P Denefle NW Wood Y Agid A Brice 2000 Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group N Engl J Med 342 1560 1567 1:CAS:528:DC%2BD3cXktVCgtbs%3D 10824074
102. E Sakata Y Yamaguchi E Kurimoto J Kikuchi S Yokoyama S Yamada H Kawahara H Yokosawa N Hattori Y Mizuno K Tanaka K Kato 2003 Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain EMBO Rep 4 301 306 1:CAS:528:DC%2BD3sXhvFynsLc%3D 12634850
103. KL Lorick JP Jensen S Fang AM Ong S Hatakeyama AM Weissman 1999 RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination Proc Natl Acad Sci USA 96 11364 11369 1:CAS:528:DyaK1MXmvVCmsb4%3D 10500182
104. HD Ulrich S Jentsch 2000 Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair EMBO J 19 3388 3397 1:CAS:528:DC%2BD3cXlt1aisrw%3D 10880451
105. H Shimura N Hattori S Kubo Y Mizuno S Asakawa S Minoshima N Shimizu K Iwai T Chiba K Tanaka T Suzuki 2000 Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nat Genet 25 302 305 1:STN:280: DC%2BD3czptF2nsw%3D%3D 10888878
106. SA Beasley VA Hristova GS Shaw 2007 Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease Proc Natl Acad Sci USA 104 3095 3100 1:CAS:528:DC%2BD2sXjtVWls7s%3D 17360614
107. EW Doss-Pepe L Chen K Madura 2005 Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains J Biol Chem 280 16619 16624 1:CAS:528:DC%2BD2MXjsFOgsr0%3D 15718234
108. JA Olzmann LS Chin 2008 Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway Autophagy 4 85 87 1:CAS:528:DC%2BD1cXks1Sgsr8%3D 17957134
109. KK Chung B Thomas X Li O Pletnikova JC Troncoso L Marsh VL Dawson TM Dawson 2004 S-nitrosylation of parkin regulates ubiquitination and compromises Parkin's protective function Science 304 1328 1331 1:CAS:528: DC%2BD2cXkt1Ggu7c%3D 15105460
110. TE Rubio la de B Luzon-Toro I Forte-Lago A Minguez-Castellanos I Ferrer S Hilfiker 2009 Combined kinase inhibition modulates parkin inactivation Hum Mol Genet 18 809 823
111. H Shimura N Hattori S Kubo M Yoshikawa T Kitada H Matsumine S Asakawa S Minoshima Y Yamamura N Shimizu Y Mizuno 1999 Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients Ann Neurol 45 668 672 1:CAS:528: DyaK1MXjt1WmsL0%3D 10319893
112. D Sha LS Chin L Li 2010 Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling Hum Mol Genet 19 352 363 1:CAS:528:DC%2BD1MXhs1WisLfP 19880420
113. IE Clark MW Dodson C Jiang JH Cao JR Huh JH Seol SJ Yoo BA Hay M Guo 2006 Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature 441 1162 1166 1:CAS:528:DC%2BD28Xmtlaiu78%3D 16672981
114. J Park SB Lee S Lee Y Kim S Song S Kim E Bae J Kim M Shong JM Kim J Chung 2006 Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin Nature 441 1157 1161 1:CAS:528:DC%2BD28Xmtlaiu70%3D 16672980
115. D Narendra A Tanaka DF Suen RJ Youle 2008 Parkin is recruited selectively to impaired mitochondria and promotes their autophagy J Cell Biol 183 795 803 1:CAS:528:DC%2BD1cXhsVOjtrjJ 19029340
116. O Rothfuss H Fischer T Hasegawa M Maisel P Leitner F Miesel M Sharma A Bornemann D Berg T Gasser N Patenge 2009 Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair Hum Mol Genet 18 3832 3850 1:CAS:528:DC%2BD1MXhtFyhurfO 19617636
117. AK Berger GP Cortese KD Amodeo A Weihofen A Letai MJ LaVoie 2009 Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release Hum Mol Genet 18 4317 4328 1:CAS:528:DC%2BD1MXhtlWhu7bJ 19679562
118. MP Burns L Zhang GW Rebeck HW Querfurth CE Moussa 2009 Parkin promotes intracellular Abeta1-42 clearance Hum Mol Genet 18 3206 3216 1:CAS:528:DC%2BD1MXps1ajtrw%3D 19483198
119. TD Helton T Otsuka MC Lee Y Mu MD Ehlers 2008 Pruning and loss of excitatory synapses by the parkin ubiquitin ligase Proc Natl Acad Sci USA 105 19492 19497 1:CAS:528:DC%2BD1cXhsFanurvK 19033459
120. E Morett P Bork 1999 A novel transactivation domain in parkin Trends Biochem Sci 24 229 231 1:CAS:528:DyaK1MXks1ansL0%3D 10366851
121. CA da Costa C Sunyach E Giaime A West O Corti A Brice S Safe PM bou-Sleiman NW Wood H Takahashi MS Goldberg J Shen F Checler 2009 Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease Nat Cell Biol 11 1370 1375 19801972
122. KD Wilkinson 1997 Regulation of ubiquitin-dependent processes by deubiquitinating enzymes FASEB J 11 1245 1256 1:CAS:528:DyaK2sXnvVKksr0%3D 9409543
123. Y Liu L Fallon HA Lashuel Z Liu PT Lansbury 2002 The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility Cell 111 209 218 1:CAS:528: DC%2BD38Xotlahsr0%3D 12408865
124. R Setsuie K Wada 2007 The functions of UCH-L1 and its relation to neurodegenerative diseases Neurochem Int 51 105 111 1:CAS:528: DC%2BD2sXosFOhur8%3D 17586089
125. K Saigoh YL Wang JG Suh T Yamanishi Y Sakai H Kiyosawa T Harada N Ichihara S Wakana T Kikuchi K Wada 1999 Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice Nat Genet 23 47 51 1:CAS:528:DyaK1MXlvFWhsLk%3D 10471497
126. ME MacDonald 1999 Gadzooks! Nat Genet 23 10 11 1:CAS:528: DyaK1MXlvFWhsrY%3D 10471487
127. M Ragland C Hutter C Zabetian K Edwards 2009 Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's disease: a HuGE review and meta-analysis Am J Epidemiol 170 1344 1357 19864305
128. E Kyratzi M Pavlaki L Stefanis 2008 The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells Hum Mol Genet 17 2160 2171 1:CAS:528:DC%2BD1cXnvV2qtr4%3D 18411255
129. J Choi AI Levey ST Weintraub HD Rees M Gearing LS Chin L Li 2004 Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J Biol Chem 279 13256 13264 1:CAS:528:DC%2BD2cXitl2ns7k%3D 14722078
130. B Gong Z Cao P Zheng OV Vitolo S Liu A Staniszewski D Moolman H Zhang M Shelanski O Arancio 2006 Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory Cell 126 775 788 1:CAS:528:DC%2BD28Xpt1akuro%3D 16923396
131. T Kabuta A Furuta S Aoki K Furuta K Wada 2008 Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy J Biol Chem 283 23731 23738 1:CAS:528:DC%2BD1cXhtVWktr%2FE 18550537
132. T Kabuta K Wada 2008 Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy Autophagy 4 827 829 1:CAS:528:DC%2BD1cXhtVynt7bE 18635949
133. Z Liu RK Meray TN Grammatopoulos RA Fredenburg MR Cookson Y Liu T Logan PT Lansbury Jr 2009 Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease Proc Natl Acad Sci USA 106 4635 4640 1:CAS:528:DC%2BD1MXktFOgsbo%3D 19261853
134. M Lopez-Salon M Alonso MR Vianna H Viola T Mello e Souza I Izquierdo JM Pasquini JH Medina 2001 The ubiquitin-proteasome cascade is required for mammalian long-term memory formation Eur J Neurosci 14 1820 1826 1:STN:280:DC%2BD387jvVSgsw%3D%3D 11860477
135. AN Hegde K Inokuchi W Pei A Casadio M Ghirardi DG Chain KC Martin ER Kandel JH Schwartz 1997 Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia Cell 89 115 126 1:CAS:528:DyaK2sXisVyksrY%3D 9094720
136. AJ Lombardino XC Li M Hertel F Nottebohm 2005 Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels Proc Natl Acad Sci USA 102 8036 8041 1:CAS:528:DC%2BD2MXkvF2isrc%3D 15911766
137. L Masino V Musi RP Menon P Fusi G Kelly TA Frenkiel Y Trottier A Pastore 2003 Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail FEBS Lett 549 21 25 1:CAS:528: DC%2BD3sXmt1Gqsr0%3D 12914917
138. P Maciel MC Costa A Ferro M Rousseau CS Santos C Gaspar J Barros GA Rouleau P Coutinho J Sequeiros 2001 Improvement in the molecular diagnosis of Machado-Joseph disease Arch Neurol 58 1821 1827 1:STN:280:DC%2BD3MnosFymtA%3D%3D 11708990
139. AP Lieberman JQ Trojanowski DG Leonard KL Chen JL Barnett JB Leverenz TD Bird Y Robitaille A Malandrini KH Fischbeck 1999 Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease Ann Neurol 46 271 273 1:STN:280:DyaK1MzntFCqtQ%3D%3D 10443897
140. S Macedo-Ribeiro L Cortes P Maciel AL Carvalho 2009 Nucleocytoplasmic shuttling activity of ataxin-3 PLoS One 4 e5834 19503814
141. CP Reina X Zhong RN Pittman 2010 Proteotoxic stress increases nuclear localization of ataxin-3 Hum Mol Genet 19 235 249 1:CAS:528:DC%2BD1MXhs1WisbzN 19843543
142. G Wang N Sawai S Kotliarova I Kanazawa N Nukina 2000 Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B Hum Mol Genet 9 1795 1803 1:CAS:528: DC%2BD3cXlsFOqurc%3D 10915768
143. BJ Winborn SM Travis SV Todi KM Scaglione P Xu AJ Williams RE Cohen J Peng HL Paulson 2008 The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains J Biol Chem 283 26436 26443 1:CAS:528:DC%2BD1cXhtFejsbbP 18599482
144. SV Todi BJ Winborn KM Scaglione JR Blount SM Travis HL Paulson 2009 Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3 EMBO J 28 372 382 1:CAS:528:DC%2BD1MXntFGhtQ%3D%3D 19153604
145. Z Ying H Wang H Fan X Zhu J Zhou E Fei G Wang 2009 Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation Hum Mol Genet 18 4268 4281 1:CAS:528:DC%2BD1MXhtlWhu7bL 19661182
146. AH Chou TH Yeh YL Kuo YC Kao MJ Jou CY Hsu SR Tsai A Kakizuka HL Wang 2006 Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL Neurobiol Dis 21 333 345 1:CAS:528:DC%2BD28XmsVGntg%3D%3D 16112867
147. J Jung K Xu D Lessing NM Bonini 2009 Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3 Hum Mol Genet 18 4843 4852 1:CAS:528:DC%2BD1MXhsVGltbvK 19783548
148. JR Babu T Geetha MW Wooten 2005 Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation J Neurochem 94 192 203 1:CAS:528:DC%2BD2MXlvFCksbY%3D 15953362
149. BJ Ramesh SM Lamar J Peng AL Strom R Kemppainen N Cox H Zhu MC Wooten MT Diaz-Meco J Moscat MW Wooten 2008 Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration J Neurochem 106 107 120
150. L Sanz P Sanchez MJ Lallena MT Diaz-Meco J Moscat 1999 The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation EMBO J 18 3044 3053 1:CAS:528:DyaK1MXktFCjtb8%3D 10356400
151. MW Wooten ML Seibenhener V Mamidipudi MT Diaz-Meco PA Barker J Moscat 2001 The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor J Biol Chem 276 7709 7712 1:CAS:528:DC%2BD3MXitFKhtL4%3D 11244088
152. L Sanz MT Diaz-Meco H Nakano J Moscat 2000 The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway EMBO J 19 1576 1586 1:CAS:528:DC%2BD3cXislymt7s%3D 10747026
153. T Geetha MW Wooten 2002 Structure and functional properties of the ubiquitin binding protein p62 FEBS Lett 512 19 24 1:CAS:528:DC%2BD38XhtlGhtrY%3D 11852044
154. S Pankiv TH Clausen T Lamark A Brech JA Bruun H Outzen A Overvatn G Bjorkoy T Johansen 2007 p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy J Biol Chem 282 24131 24145 1:CAS:528:DC%2BD2sXoslOntb0%3D 17580304
155. A Puls S Schmidt F Grawe S Stabel 1997 Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein Proc Natl Acad Sci USA 94 6191 6196 1:CAS:528:DyaK2sXjvFCntb0%3D 9177193
156. MW Wooten X Hu JR Babu ML Seibenhener T Geetha MG Paine MC Wooten 2006 Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease J Biomed Biotechnol 2006 62079 17047309
157. J Gal AL Strom DM Kwinter R Kilty J Zhang P Shi W Fu MW Wooten H Zhu 2009 Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism J Neurochem 111 1062 1073 1:CAS:528: DC%2BD1MXhsVSkur3M 19765191
158. ML Seibenhener T Geetha MW Wooten 2007 Sequestosome 1/p62-more than just a scaffold FEBS Lett 581 175 179 1:CAS:528:DC%2BD2sXnslyrsw%3D%3D 17188686
159. E Kuusisto A Salminen I Alafuzoff 2001 Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies Neuroreport 12 2085 2090 1:CAS:528:DC%2BD3MXls1enurc%3D 11447312
160. K Zatloukal C Stumptner A Fuchsbichler H Heid M Schnoelzer L Kenner R Kleinert M Prinz A Aguzzi H Denk 2002 p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases Am J Pathol 160 255 263 1:CAS:528:DC%2BD38XnvFegtw%3D%3D 11786419
161. Y Furukawa E Iseki H Hino A Kanai T Odawara K Kosaka 2004 Ubiquitin and ubiquitin-related proteins in neurons and dendrites of brains of atypical Pick's disease without Pick bodies Neuropathology 24 38 45 15068171
162. T Nakano K Nakaso K Nakashima E Ohama 2004 Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum Acta Neuropathol (Berl) 107 359 364 1:CAS:528:DC%2BD2cXitFCnsbc%3D
163. E Kuusisto A Salminen I Alafuzoff 2002 Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation Neuropathol Appl Neurobiol 28 228 237 1:CAS:528:DC%2BD38XlsVKkt7c%3D 12060347
164. K Nakaso Y Yoshimoto T Nakano T Takeshima Y Fukuhara K Yasui S Araga T Yanagawa T Ishii K Nakashima 2004 Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease Brain Res 1012 42 51 1:CAS:528: DC%2BD2cXktF2ltLg%3D 15158159
165. U Nagaoka K Kim NR Jana H Doi M Maruyama K Mitsui F Oyama N Nukina 2004 Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions J Neurochem 91 57 68 1:CAS:528:DC%2BD2cXosVKqur8%3D 15379887
166. L Nan Y Wu F Bardag-Gorce J Li BA French AN Fu T Francis J Vu SW French 2004 p62 is involved in the mechanism of Mallory body formation Exp Mol Pathol 77 168 175 1:CAS:528:DC%2BD2cXovVKks7o%3D 15507232
167. Y Du MC Wooten MW Wooten 2009 Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease Neurobiol Dis 35 302 310 1:CAS:528:DC%2BD1MXotFCgtL0%3D 19481605
168. PG Richardson P Sonneveld MW Schuster D Irwin EA Stadtmauer T Facon JL Harousseau D Ben-Yehuda S Lonial H Goldschmidt D Reece JF San-Miguel J Blade M Boccadoro J Cavenagh WS Dalton AL Boral DL Esseltine JB Porter D Schenkein KC Anderson 2005 Bortezomib or high-dose dexamethasone for relapsed multiple myeloma N Engl J Med 352 2487 2498 1:CAS:528:DC%2BD2MXltlaksLc%3D 15958804
169. V Ustrell L Hoffman G Pratt M Rechsteiner 2002 PA200, a nuclear proteasome activator involved in DNA repair EMBO J 21 3516 3525 1:CAS:528:DC%2BD38XlsFCgur4%3D 12093752
170. J Ortega JB Heymann AV Kajava V Ustrell M Rechsteiner AC Steven 2005 The axial channel of the 20S proteasome opens upon binding of the PA200 activator J Mol Biol 346 1221 1227 1:CAS:528:DC%2BD2MXhtlOlu7k%3D 15713476
171. J Blickwedehl M Agarwal C Seong RK Pandita T Melendy P Sung TK Pandita N Bangia 2008 Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability Proc Natl Acad Sci USA 105 16165 16170 1:CAS:528:DC%2BD1cXhtlSju7rE 18845680
172. I Mao J Liu X Li H Luo 2008 REGgamma, a proteasome activator and beyond? Cell Mol Life Sci 65 3971 3980 1:CAS:528:DC%2BD1cXhsFCgs7nL 18679578
173. K Schwarz M Eggers A Soza UH Koszinowski PM Kloetzel M Groettrup 2000 The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition Eur J Immunol 30 3672 3679 1:CAS:528:DC%2BD3MXpt12k 11169410
174. DA Ferrington SA Hussong H Roehrich RJ Kapphahn SM Kavanaugh ND Heuss DS Gregerson 2008 Immunoproteasome responds to injury in the retina and brain J Neurochem 106 158 169 1:CAS:528:DC%2BD1cXot1Ogsrs%3D 18346202
175. M Mishto E Bellavista A Santoro A Stolzing C Ligorio B Nacmias L Spazzafumo M Chiappelli F Licastro S Sorbi A Pession T Ohm T Grune C Franceschi 2006 Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains Neurobiol Aging 27 54 66 1:CAS:528:DC%2BD2MXht1egsr3E 16298241
176. M Diaz-Hernandez F Hernandez E Martin-Aparicio P Gomez-Ramos MA Moran JG Castano I Ferrer J Avila JJ Lucas 2003 Neuronal induction of the immunoproteasome in Huntington's disease J Neurosci 23 11653 11661 1:CAS:528:DC%2BD2cXhsFyntA%3D%3D 14684867
177. H Seo KC Sonntag W Kim E Cattaneo O Isacson 2007 Proteasome activator enhances survival of Huntington's disease neuronal model cells PLoS One 2 e238 17327906
178. R Verma NR Peters M D'Onofrio GP Tochtrop KM Sakamoto R Varadan M Zhang P Coffino D Fushman RJ Deshaies RW King 2004 Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain Science 306 117 120 1:CAS:528:DC%2BD2cXnvFChur8%3D 15459393
179. EM Hol DF Fischer H Ovaa W Scheper 2006 Ubiquitin proteasome system as a pharmacological target in neurodegeneration Expert Rev Neurother 6 1337 1347 1:CAS:528:DC%2BD28XhtVCnt7bP 17009921
180. J Hanna D Finley 2007 A proteasome for all occasions FEBS Lett 581 2854 2861 1:CAS:528:DC%2BD2sXmtlWitLY%3D 17418826
181. N Chondrogianni C Tzavelas AJ Pemberton IP Nezis AJ Rivett ES Gonos 2005 Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates J Biol Chem 280 11840 11850 1:CAS:528:DC%2BD2MXisVyjtbY%3D 15661736
182. N Chondrogianni ES Gonos 2007 Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence Exp Gerontol 42 899 903 1:CAS:528:DC%2BD2sXpsFKnsbk%3D 17349762
183. A Stanhill CM Haynes Y Zhang G Min MC Steele J Kalinina E Martinez CM Pickart XP Kong D Ron 2006 An arsenite-inducible 19S regulatory particle-associated protein adapts proteasomes to proteotoxicity Mol Cell 23 875 885 1:CAS:528:DC%2BD28XhtVKgu7zO 16973439
184. B Dahlmann M Rutschmann L Kuehn H Reinauer 1985 Activation of the multicatalytic proteinase from rat skeletal muscle by fatty acids or sodium dodecyl sulphate Biochem J 228 171 177 1:CAS:528:DyaL2MXktlCjs7o%3D 3890840
185. N Watanabe S Yamada 1996 Activation of 20S proteasomes from spinach leaves by fatty acids Plant Cell Physiol 37 147 151 1:CAS:528:DyaK28XhvVGju7g%3D 8665092
186. S Wilk WE Chen 1997 Synthetic peptide-based activators of the proteasome Mol Biol Rep 24 119 124 1:CAS:528:DyaK2sXks1amsrY%3D 9228292
187. AF Kisselev D Kaganovich AL Goldberg 2002 Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes. Evidence for peptide-induced channel opening in the alpha-rings J Biol Chem 277 22260 22270 1:CAS:528:DC%2BD38XltVGksLs%3D 11927581
188. M Katsiki N Chondrogianni I Chinou AJ Rivett ES Gonos 2007 The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts Rejuvenation Res 10 157 172 1:CAS:528:DC%2BD2sXms1yqt70%3D 17518699
189. MK Kwak N Wakabayashi JL Greenlaw M Yamamoto TW Kensler 2003 Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway Mol Cell Biol 23 8786 8794 1:CAS:528:DC%2BD3sXptFaitrs%3D 14612418
190. MK Kwak JM Cho B Huang S Shin TW Kensler 2007 Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells Free Radic Biol Med 43 809 817 1:CAS:528:DC%2BD2sXotlSmsLc%3D 17664144
191. RK Thimmulappa RJ Fuchs D Malhotra C Scollick K Traore JH Bream MA Trush KT Liby MB Sporn TW Kensler S Biswal 2007 Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils Antioxid Redox Signal 9 1963 1970 1:CAS:528:DC%2BD2sXht1ajtbjE 17822364
192. L Huang P Ho CH Chen 2007 Activation and inhibition of the proteasome by betulinic acid and its derivatives FEBS Lett 581 4955 4959 1:CAS:528: DC%2BD2sXhtFGku7nN 17904555
193. RZ Orlowski DJ Kuhn 2008 Proteasome inhibitors in cancer therapy: lessons from the first decade Clin Cancer Res 14 1649 1657 1:CAS:528: DC%2BD1cXjtlejt74%3D 18347166
194. N Chondrogianni I Petropoulos C Franceschi B Friguet ES Gonos 2000 Fibroblast cultures from healthy centenarians have an active proteasome Exp Gerontol 35 721 728 1:CAS:528:DC%2BD3cXot1WqsLk%3D 11053662
195. KM Sakamoto KB Kim A Kumagai F Mercurio CM Crews RJ Deshaies 2001 Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation Proc Natl Acad Sci USA 98 8554 8559 1:CAS:528:DC%2BD3MXls1Wisbk%3D 11438690
196. AR Schneekloth M Pucheault HS Tae CM Crews 2008 Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics Bioorg Med Chem Lett 18 5904 5908 1:CAS:528:DC%2BD1cXhtlOht7rL 18752944
197. T Yasuda S Miyachi R Kitagawa K Wada T Nihira YR Ren Y Hirai N Ageyama K Terao T Shimada M Takada Y Mizuno H Mochizuki 2007 Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates Neuroscience 144 743 753 1:CAS:528:DC%2BD28Xht12qsL%2FO 17101231
198. M Zhang M Windheim SM Roe M Peggie P Cohen C Prodromou LH Pearl 2005 Chaperoned ubiquitylation-crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex Mol Cell 20 525 538 1:CAS:528: DC%2BD2MXht12msr%2FF 16307917
199. Y Shin J Klucken C Patterson BT Hyman PJ McLean 2005 The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways J Biol Chem 280 23727 23734 1:CAS:528:DC%2BD2MXltlKhsr4%3D 15845543
200. HS Ko R Bailey WW Smith Z Liu JH Shin YI Lee YJ Zhang H Jiang CA Ross DJ Moore C Patterson L Petrucelli TM Dawson VL Dawson 2009 CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity Proc Natl Acad Sci USA 106 2897 2902 1:CAS:528:DC%2BD1MXislSktL8%3D 19196961
201. N Sahara M Murayama T Mizoroki M Urushitani Y Imai R Takahashi S Murata K Tanaka A Takashima 2005 In vivo evidence of CHIP up-regulation attenuating tau aggregation J Neurochem 94 1254 1263 1:CAS:528:DC%2BD2MXpvF2qur0%3D 16111477
202. S Oddo A Caccamo B Tseng D Cheng V Vasilevko DH Cribbs FM LaFerla 2008 Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology J Neurosci 28 12163 12175 1:CAS:528:DC%2BD1cXhsVGmtLvM 19020010
203. CA Dickey M Yue WL Lin DW Dickson JH Dunmore WC Lee C Zehr G West S Cao AM Clark GA Caldwell KA Caldwell C Eckman C Patterson M Hutton L Petrucelli 2006 Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species J Neurosci 26 6985 6996 1:CAS:528:DC%2BD28XmvVGqt70%3D 16807328
204. NR Jana P Dikshit A Goswami S Kotliarova S Murata K Tanaka N Nukina 2005 Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes J Biol Chem 280 11635 11640 1:CAS:528:DC%2BD2MXisVyjt7g%3D 15664989
205. Y Sha L Pandit S Zeng NT Eissa 2009 A critical role for CHIP in the aggresome pathway Mol Cell Biol 29 116 128 1:CAS:528:DC%2BD1MXhsVChtL0%3D 18955503
206. MJ Matunis CM Pickart 2005 Beginning at the end with SUMO Nat Struct Mol Biol 12 565 566 1:CAS:528:DC%2BD2MXlsl2itbc%3D 15999109
207. V Dorval PE Fraser 2007 SUMO on the road to neurodegeneration Biochim Biophys Acta 1773 694 706 1:CAS:528:DC%2BD2sXmtVans7s%3D 17475350
208. A Janer A Werner J Takahashi-Fujigasaki A Daret H Fujigasaki K Takada C Duyckaerts A Brice A Dejean A Sittler 2010 SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7 Hum Mol Genet 19 181 195 1:CAS:528:DC%2BD1MXhsFGhu7jP 19843541
209. S Mukherjee M Thomas N Dadgar AP Lieberman JA Iniguez-Lluhi 2009 Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation J Biol Chem 284 21296 21306 1:CAS:528:DC%2BD1MXpt1Wju7s%3D 19497852
210. AL Goldberg 2003 Protein degradation and protection against misfolded or damaged proteins Nature 426 895 899 1:CAS:528:DC%2BD3sXpvVGmtbc%3D 14685250
211. AM Gorman 2008 Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling J Cell Mol Med 12 2263 2280 1:CAS:528:DC%2BD1MXht1WhtLc%3D 18624755
212. P Waldmeier D Bozyczko-Coyne M Williams JL Vaught 2006 Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases Biochem Pharmacol 72 1197 1206 1:CAS:528:DC%2BD28XhtFSrtLzF 16901468
213. Schmidt-Glenewinkel T, Figueiredo-Pereira ME (2006) Inflammation as a mediator of oxidative stress and UPS dysfunction. In: Stefanis L, Keller JN (eds) The proteasome in neurodegeneration. Springer, New York, pp 105-131
214. WJ Streit KR Miller KO Lopes E Njie 2008 Microglial degeneration in the aging brain-bad news for neurons? Front Biosci 13 3423 3438 1:CAS:528: DC%2BD1cXnsVKqtr8%3D 18508444
215. P Brundin JY Li JL Holton O Lindvall T Revesz 2008 Research in motion: the enigma of Parkinson's disease pathology spread Nat Rev Neurosci 9 741 745 1:CAS:528:DC%2BD1cXhtFeit7fP 18769444
216. O Ullrich A Diestel I Bechmann M Homberg T Grune R Hass R Nitsch 2001 Turnover of oxidatively damaged nuclear proteins in BV-2 microglial cells is linked to their activation state by poly-ADP-ribose polymerase FASEB J 15 1460 1462 1:CAS:528:DC%2BD3MXlvVCjuro%3D 11387257
217. KM Lucin T Wyss-Coray 2009 Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 110 122 1:CAS:528:DC%2BD1MXhsFajsbbO 19840553